These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19236122)

  • 1. Effect of macrolide and fluoroquinolone antibacterials on the risk of ventricular arrhythmia and cardiac arrest: an observational study in Italy using case-control, case-crossover and case-time-control designs.
    Zambon A; Polo Friz H; Contiero P; Corrao G
    Drug Saf; 2009; 32(2):159-67. PubMed ID: 19236122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrolide and fluoroquinolone mediated cardiac arrhythmias: clinical considerations and comprehensive review.
    Cornett E; Novitch MB; Kaye AD; Pann CA; Bangalore HS; Allred G; Bral M; Jhita PK; Kaye AM
    Postgrad Med; 2017 Sep; 129(7):715-724. PubMed ID: 28770640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoroquinolone use and serious arrhythmias: A nationwide case-crossover study.
    Porta L; Lee MG; Hsu WT; Hsu TC; Tsai TY; Lee CC
    Resuscitation; 2019 Jun; 139():262-268. PubMed ID: 31029713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generating signals of drug-adverse effects from prescription databases and application to the risk of arrhythmia associated with antibacterials.
    Corrao G; Botteri E; Bagnardi V; Zambon A; Carobbio A; Falcone C; Leoni O
    Pharmacoepidemiol Drug Saf; 2005 Jan; 14(1):31-40. PubMed ID: 15390219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated Cardiac Risk Associated With Macrolides and Fluoroquinolones Decreases Substantially When Adjusting for Patient Characteristics and Comorbidities.
    Polgreen LA; Riedle BN; Cavanaugh JE; Girotra S; London B; Schroeder MC; Polgreen PM
    J Am Heart Assoc; 2018 Apr; 7(9):. PubMed ID: 29680825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the effect of transient exposure on the risk of acute events by means of time-window designs: an application to fluoroquinolone antibacterials and arrhythmia.
    Corrao G; Botteri E; Bertù L; Zambon A; Favilli S
    Pharmacoepidemiol Drug Saf; 2006 Jan; 15(1):31-7. PubMed ID: 15954079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial.
    Postma DF; Spitoni C; van Werkhoven CH; van Elden LJR; Oosterheert JJ; Bonten MJM
    BMC Infect Dis; 2019 Jan; 19(1):17. PubMed ID: 30612559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoroquinolones and the risk of serious arrhythmia: a population-based study.
    Lapi F; Wilchesky M; Kezouh A; Benisty JI; Ernst P; Suissa S
    Clin Infect Dis; 2012 Dec; 55(11):1457-65. PubMed ID: 22865870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study.
    Chou HW; Wang JL; Chang CH; Lai CL; Lai MS; Chan KA
    Clin Infect Dis; 2015 Feb; 60(4):566-77. PubMed ID: 25409476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral fluoroquinolone use and serious arrhythmia: bi-national cohort study.
    Inghammar M; Svanström H; Melbye M; Pasternak B; Hviid A
    BMJ; 2016 Feb; 352():i843. PubMed ID: 26920666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular safety of macrolide and fluoroquinolone antibiotics: An analysis of the WHO database of adverse drug reactions.
    Bonaldo G; Andriani LA; D'Annibali O; Motola D; Vaccheri A
    Pharmacoepidemiol Drug Saf; 2019 Nov; 28(11):1457-1463. PubMed ID: 31423694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of tendinitis provoked by fluoroquinolone treatment: a case-control study.
    Corrao G; Zambon A; Bertù L; Mauri A; Paleari V; Rossi C; Venegoni M
    Drug Saf; 2006; 29(10):889-96. PubMed ID: 16970512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrolide antibiotics and the risk of ventricular arrhythmia in older adults.
    Trac MH; McArthur E; Jandoc R; Dixon SN; Nash DM; Hackam DG; Garg AX
    CMAJ; 2016 Apr; 188(7):E120-E129. PubMed ID: 26903359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Fluoroquinolone Use and Hospitalization With Aortic Aneurysm or Aortic Dissection.
    Brown JP; Wing K; Leyrat C; Evans SJ; Mansfield KE; Wong AYS; Smeeth L; Galwey NW; Douglas IJ
    JAMA Cardiol; 2023 Sep; 8(9):865-870. PubMed ID: 37585175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacosafety of fluoroquinolone and macrolide antibiotics in the clinical care of patients with myasthenia gravis.
    Pham Nguyen TP; Leonard CE; Bird SJ; Willis AW; Hamedani AG
    Muscle Nerve; 2021 Aug; 64(2):156-162. PubMed ID: 33719062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of azithromycin and risk of ventricular arrhythmia.
    Trifirò G; de Ridder M; Sultana J; Oteri A; Rijnbeek P; Pecchioli S; Mazzaglia G; Bezemer I; Garbe E; Schink T; Poluzzi E; Frøslev T; Molokhia M; Diemberger I; Sturkenboom MCJM
    CMAJ; 2017 Apr; 189(15):E560-E568. PubMed ID: 28420680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial use: a risk factor or a protective factor for acquiring campylobacteriosis?
    Koningstein M; Simonsen J; Helms M; Hald T; Mølbak K
    Clin Infect Dis; 2011 Oct; 53(7):644-50. PubMed ID: 21890769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of oral ciprofloxacin, levofloxacin, ofloxacin and moxifloxacin with the risk of serious ventricular arrhythmia: a nationwide cohort study in Korea.
    Cho Y; Park HS
    BMJ Open; 2018 Sep; 8(9):e020974. PubMed ID: 30269062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant use of lansoprazole and ceftriaxone is associated with an increased risk of ventricular arrhythmias and cardiac arrest in a large Japanese hospital database.
    Mitsuboshi S; Imai S; Kizaki H; Hori S
    J Infect; 2024 Aug; 89(2):106202. PubMed ID: 38897240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral fluoroquinolones and risk of aortic aneurysm or dissection: A nationwide population-based propensity score-matched cohort study.
    Garg M; Venugopalan V; Vouri SM; Diaby V; Iovine NM; Park H
    Pharmacotherapy; 2023 Sep; 43(9):883-893. PubMed ID: 37381584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.